CERCAM
gene geneOn this page
Also known as GLT25D3
Summary
CERCAM (cerebral endothelial cell adhesion molecule, HGNC:23723) is a protein-coding gene on chromosome 9q34.11, encoding Inactive glycosyltransferase 25 family member 3 (Q5T4B2). Probable cell adhesion protein involved in leukocyte transmigration across the blood-brain barrier.
Enables identical protein binding activity. Acts upstream of or within cell adhesion. Predicted to be located in plasma membrane.
Source: NCBI Gene 51148 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 143 total — 2 pathogenic
- MANE Select transcript:
NM_016174
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23723 |
| Approved symbol | CERCAM |
| Name | cerebral endothelial cell adhesion molecule |
| Location | 9q34.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | GLT25D3 |
| Ensembl gene | ENSG00000167123 |
| Ensembl biotype | protein_coding |
| OMIM | 616626 |
| Entrez | 51148 |
Gene structure
Transcript identifiers
Ensembl transcripts: 23 — 17 protein_coding, 4 protein_coding_CDS_not_defined, 2 retained_intron
ENST00000372838, ENST00000372842, ENST00000411852, ENST00000420034, ENST00000420512, ENST00000447915, ENST00000463535, ENST00000472858, ENST00000483737, ENST00000483893, ENST00000487001, ENST00000493788, ENST00000895870, ENST00000895871, ENST00000895872, ENST00000895873, ENST00000951767, ENST00000951768, ENST00000951769, ENST00000951770, ENST00000951771, ENST00000951772, ENST00000951773
RefSeq mRNA: 2 — MANE Select: NM_016174
NM_001286760, NM_016174
CCDS: CCDS6901, CCDS69675
Canonical transcript exons
ENST00000372838 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001109960 | 128434410 | 128434613 |
| ENSE00001218481 | 128436849 | 128437347 |
| ENSE00001720937 | 128420857 | 128421074 |
| ENSE00001785614 | 128424138 | 128424272 |
| ENSE00003525804 | 128428302 | 128428421 |
| ENSE00003534701 | 128431171 | 128431303 |
| ENSE00003591901 | 128422868 | 128422978 |
| ENSE00003605963 | 128428930 | 128429036 |
| ENSE00003612922 | 128434102 | 128434229 |
| ENSE00003626739 | 128424410 | 128424614 |
| ENSE00003660314 | 128428757 | 128428833 |
| ENSE00003788370 | 128435653 | 128435905 |
| ENSE00003790268 | 128423146 | 128423263 |
Expression profiles
Bgee: expression breadth ubiquitous, 209 present calls, max score 99.35.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 70.0487 / max 993.3746, expressed in 1707 samples.
FANTOM5 promoters (18 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 98776 | 61.0149 | 1700 |
| 98766 | 1.8305 | 88 |
| 98775 | 1.2942 | 806 |
| 98769 | 1.0429 | 72 |
| 98768 | 0.7964 | 76 |
| 98778 | 0.7471 | 432 |
| 98767 | 0.7373 | 80 |
| 98777 | 0.4896 | 264 |
| 98780 | 0.4372 | 266 |
| 98770 | 0.2517 | 65 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| C1 segment of cervical spinal cord | UBERON:0006469 | 99.35 | gold quality |
| spinal cord | UBERON:0002240 | 99.20 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 99.17 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 99.09 | gold quality |
| putamen | UBERON:0001874 | 98.88 | gold quality |
| medulla oblongata | UBERON:0001896 | 98.77 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 98.63 | gold quality |
| ventral tegmental area | UBERON:0002691 | 98.46 | gold quality |
| stromal cell of endometrium | CL:0002255 | 98.37 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 98.23 | gold quality |
| midbrain | UBERON:0001891 | 98.16 | gold quality |
| substantia nigra | UBERON:0002038 | 98.12 | gold quality |
| amygdala | UBERON:0001876 | 98.05 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 97.93 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 97.87 | gold quality |
| caudate nucleus | UBERON:0001873 | 97.55 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 97.43 | gold quality |
| hypothalamus | UBERON:0001898 | 97.32 | gold quality |
| right frontal lobe | UBERON:0002810 | 97.18 | gold quality |
| nucleus accumbens | UBERON:0001882 | 96.81 | gold quality |
| corpus callosum | UBERON:0002336 | 96.72 | gold quality |
| adenohypophysis | UBERON:0002196 | 96.08 | gold quality |
| Ammon’s horn | UBERON:0001954 | 95.89 | gold quality |
| pituitary gland | UBERON:0000007 | 95.79 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 95.62 | gold quality |
| pons | UBERON:0000988 | 94.98 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 94.78 | gold quality |
| right coronary artery | UBERON:0001625 | 94.62 | gold quality |
| ascending aorta | UBERON:0001496 | 94.35 | gold quality |
| thoracic aorta | UBERON:0001515 | 94.32 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 5.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-30 | yes | 1381.85 |
| E-HCAD-25 | yes | 49.68 |
| E-CURD-112 | yes | 15.53 |
| E-HCAD-13 | yes | 12.72 |
| E-ANND-3 | yes | 11.49 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
62 targeting CERCAM, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4713-3P | 100.00 | 65.92 | 505 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-454-3P | 99.91 | 74.01 | 1925 |
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-130A-3P | 99.90 | 73.31 | 1861 |
| HSA-MIR-130B-3P | 99.90 | 73.27 | 1850 |
| HSA-MIR-301A-3P | 99.90 | 73.15 | 1839 |
| HSA-MIR-301B-3P | 99.90 | 73.19 | 1836 |
| HSA-MIR-3666 | 99.90 | 73.24 | 1833 |
| HSA-MIR-4295 | 99.90 | 73.11 | 1838 |
| HSA-MIR-17-5P | 99.89 | 73.83 | 2665 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-106B-5P | 99.88 | 74.72 | 2795 |
| HSA-MIR-20A-5P | 99.88 | 74.76 | 2769 |
| HSA-MIR-20B-5P | 99.88 | 74.01 | 2621 |
| HSA-MIR-519D-3P | 99.88 | 73.97 | 2607 |
| HSA-MIR-526B-3P | 99.88 | 74.06 | 2587 |
| HSA-MIR-93-5P | 99.88 | 73.98 | 2606 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
Literature-anchored findings (GeneRIF, showing 1)
- The oncogenic role of the cerebral endothelial cell adhesion molecule (CERCAM) in bladder cancer cells in vitro and in vivo. (PMID:34105305)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cercam | ENSDARG00000079049 |
| mus_musculus | Cercam | ENSMUSG00000039787 |
| rattus_norvegicus | Cercam | ENSRNOG00000026604 |
| drosophila_melanogaster | CG31915 | FBGN0051915 |
| caenorhabditis_elegans | WBGENE00008426 |
Paralogs (5): PLOD1 (ENSG00000083444), PLOD3 (ENSG00000106397), COLGALT1 (ENSG00000130309), PLOD2 (ENSG00000152952), COLGALT2 (ENSG00000198756)
Protein
Protein identifiers
Inactive glycosyltransferase 25 family member 3 — Q5T4B2 (reviewed: Q5T4B2)
Alternative names: Cerebral endothelial cell adhesion molecule
All UniProt accessions (5): B7ZBS8, B7ZBS9, B7ZBT0, Q5T4B2, X6RL83
UniProt curated annotations — full annotation on UniProt →
Function. Probable cell adhesion protein involved in leukocyte transmigration across the blood-brain barrier. Does not express any beta-galactosyltransferase activity in vitro.
Subcellular location. Endoplasmic reticulum lumen.
Tissue specificity. Ubiquitous. Highly expressed in secretory and nervous tissues.
Similarity. Belongs to the glycosyltransferase 25 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5T4B2-1 | 1 | yes |
| Q5T4B2-2 | 2 |
RefSeq proteins (2): NP_001273689, NP_057258* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002654 | Glyco_trans_25 | Domain |
| IPR029044 | Nucleotide-diphossugar_trans | Homologous_superfamily |
| IPR050757 | Collagen_mod_GT25 | Family |
Pfam: PF01755
UniProt features (17 total): mutagenesis site 5, glycosylation site 4, sequence conflict 2, signal peptide 1, chain 1, region of interest 1, short sequence motif 1, compositionally biased region 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5T4B2-F1 | 89.17 | 0.78 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (4): 75, 153, 237, 360
Mutagenesis-validated functional residues (5):
| Position | Phenotype |
|---|---|
| 440 | no effect on lack of galactosyltransferase activity in a chimeric construct with colgalt1. exhibits some galactosyltrans |
| 450 | exhibits some galactosyltransferase activity; when associated with d-440; m-451; q-452 and v-453 in a chimeric construct |
| 451 | exhibits some galactosyltransferase activity; when associated with d-440; r-450; q-452 and v-453 in a chimeric construct |
| 452 | exhibits some galactosyltransferase activity; when associated with d-440; r-450; m-451 and v-453 in a chimeric construct |
| 453 | exhibits some galactosyltransferase activity; when associated with d-440; r-450; m-451 and q-452 in a chimeric construct |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 120 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_UP, GGGTGGRR_PAX4_03, GOBP_CELL_CELL_ADHESION, ZIC1_01, GOBP_LEUKOCYTE_CELL_CELL_ADHESION, DOUGLAS_BMI1_TARGETS_UP, CTGYNNCTYTAA_UNKNOWN, AP2_Q6_01, AP2GAMMA_01, GOCC_ENDOPLASMIC_RETICULUM_LUMEN, GOMF_HEXOSYLTRANSFERASE_ACTIVITY, GOMF_GLYCOSYLTRANSFERASE_ACTIVITY, GOMF_GALACTOSYLTRANSFERASE_ACTIVITY, GOMF_UDP_GLYCOSYLTRANSFERASE_ACTIVITY, AP2ALPHA_01
GO Biological Process (2): cell adhesion (GO:0007155), leukocyte cell-cell adhesion (GO:0007159)
GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (3): endoplasmic reticulum lumen (GO:0005788), plasma membrane (GO:0005886), endoplasmic reticulum (GO:0005783)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular process | 1 |
| cell-cell adhesion | 1 |
| protein binding | 1 |
| binding | 1 |
| endoplasmic reticulum | 1 |
| intracellular organelle lumen | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
504 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CERCAM | LYPLA2 | O95372 | 453 |
| CERCAM | LHPP | Q9H008 | 445 |
| CERCAM | AHNAK | Q09666 | 396 |
| CERCAM | STOX2 | Q9P2F5 | 389 |
| CERCAM | TMEM217 | Q8N7C4 | 387 |
| CERCAM | TMEM217B | A0A494BZU4 | 387 |
| CERCAM | NF2 | P35240 | 369 |
| CERCAM | NRN1L | Q496H8 | 351 |
| CERCAM | ERICH5 | Q6P6B1 | 348 |
| CERCAM | ZFP14 | Q9HCL3 | 331 |
| CERCAM | TMEM35A | Q53FP2 | 328 |
| CERCAM | SPDYE1 | Q8NFV5 | 326 |
| CERCAM | FAM228B | P0C875 | 326 |
| CERCAM | MANBAL | Q9NQG1 | 322 |
| CERCAM | CCDC86 | Q9H6F5 | 320 |
| CERCAM | LRRC57 | Q8N9N7 | 320 |
IntAct
188 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| C1QTNF9 | C1QTNF9B | psi-mi:“MI:0914”(association) | 0.780 |
| CA10 | WDHD1 | psi-mi:“MI:0914”(association) | 0.640 |
| CERCAM | ABHD5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GEMIN4 | CERCAM | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | CERCAM | psi-mi:“MI:0915”(physical association) | 0.560 |
| CERCAM | CERCAM | psi-mi:“MI:0915”(physical association) | 0.560 |
| CERCAM | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KLHL38 | CERCAM | psi-mi:“MI:0915”(physical association) | 0.560 |
| LASP1 | CERCAM | psi-mi:“MI:0915”(physical association) | 0.560 |
| SOHLH1 | CERCAM | psi-mi:“MI:0915”(physical association) | 0.560 |
| CERCAM | FNDC11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CERCAM | FANCL | psi-mi:“MI:0915”(physical association) | 0.560 |
| CERCAM | KRTAP3-3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CERCAM | UBL5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CERCAM | P4HA3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CERCAM | TENT5B | psi-mi:“MI:0915”(physical association) | 0.560 |
| CERCAM | MAGED1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| POGZ | CERCAM | psi-mi:“MI:0915”(physical association) | 0.560 |
| POU4F2 | CERCAM | psi-mi:“MI:0915”(physical association) | 0.560 |
| CERCAM | KRTAP26-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OTX1 | CERCAM | psi-mi:“MI:0915”(physical association) | 0.560 |
| CERCAM | ATG9A | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-2 | CERCAM | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP15-1 | CERCAM | psi-mi:“MI:0915”(physical association) | 0.560 |
| VENTX | CERCAM | psi-mi:“MI:0915”(physical association) | 0.560 |
| HOXA1 | CERCAM | psi-mi:“MI:0915”(physical association) | 0.560 |
| CREB5 | CERCAM | psi-mi:“MI:0915”(physical association) | 0.560 |
| CERCAM | KRTAP8-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CERCAM | RHOXF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (146): GOPC (Two-hybrid), CERCAM (Affinity Capture-MS), CERCAM (Affinity Capture-MS), CERCAM (Affinity Capture-MS), CERCAM (Affinity Capture-MS), CERCAM (Affinity Capture-MS), CERCAM (Affinity Capture-MS), CERCAM (Affinity Capture-MS), CERCAM (Affinity Capture-MS), CERCAM (Affinity Capture-MS), CERCAM (Affinity Capture-MS), CERCAM (Affinity Capture-MS), CERCAM (Affinity Capture-MS), CERCAM (Affinity Capture-MS), CERCAM (Affinity Capture-MS)
ESM2 similar proteins: A0JPH3, A1YGR5, A3KGW5, A5PMF6, A7MB73, O00469, O14638, O43909, O77588, P06802, P15396, P24802, P26572, P27115, P27808, P50127, P79948, P79949, P97675, Q02809, Q09325, Q32NJ7, Q3L7M0, Q5IGR6, Q5R5M5, Q5R9N3, Q5T4B2, Q5U309, Q5U483, Q5XPT3, Q5ZLK4, Q63321, Q66PG1, Q66PG2, Q66PG4, Q6DYE8, Q6NVG7, Q6P7A1, Q6P9A2, Q6PA90
Diamond homologs: A0JPH3, A3KGW5, A5PK45, A5PMF6, A7MB73, O77588, Q17FB8, Q29NU5, Q5T4B2, Q5U309, Q5U367, Q5U483, Q6NVG7, Q7Q021, Q811A3, Q8IPK4, Q8IYK4, Q8K297, Q8NBJ5, Q9R0E1, Q9R0E2, P57033, P71398, Q50947, Q50950, Q51116, Q51117, Q57394, Q5UQ62, Q5UQC3, Q02809, Q5R9N3, Q9VTH0, Q03974, Q63321, Q05770, Q57125, O60568, Q5R6K5, O00469
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
143 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 118 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 815297 | GRCh37/hg19 9q34.11(chr9:130957344-132310210)x1 | Pathogenic |
| 984763 | GRCh37/hg19 9q34.11(chr9:130412438-131423964)x1 | Pathogenic |
SpliceAI
2240 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:128422866:A:AG | acceptor_gain | 1.0000 |
| 9:128422866:AGGTG:A | acceptor_loss | 1.0000 |
| 9:128422867:G:GG | acceptor_gain | 1.0000 |
| 9:128422867:G:GT | acceptor_loss | 1.0000 |
| 9:128422867:GGTGT:G | acceptor_gain | 1.0000 |
| 9:128422958:G:GT | donor_gain | 1.0000 |
| 9:128422968:G:GT | donor_gain | 1.0000 |
| 9:128423219:G:GT | donor_gain | 1.0000 |
| 9:128423239:G:GT | donor_gain | 1.0000 |
| 9:128423240:A:T | donor_gain | 1.0000 |
| 9:128423262:TGGTG:T | donor_loss | 1.0000 |
| 9:128423264:G:A | donor_loss | 1.0000 |
| 9:128423265:T:A | donor_loss | 1.0000 |
| 9:128423269:G:GT | donor_gain | 1.0000 |
| 9:128424407:CA:C | acceptor_loss | 1.0000 |
| 9:128424408:A:AG | acceptor_gain | 1.0000 |
| 9:128424408:A:T | acceptor_loss | 1.0000 |
| 9:128424408:AG:A | acceptor_gain | 1.0000 |
| 9:128424408:AGG:A | acceptor_gain | 1.0000 |
| 9:128424409:G:GA | acceptor_gain | 1.0000 |
| 9:128424409:GG:G | acceptor_gain | 1.0000 |
| 9:128424409:GGG:G | acceptor_gain | 1.0000 |
| 9:128424409:GGGCT:G | acceptor_gain | 1.0000 |
| 9:128424611:GCTG:G | donor_gain | 1.0000 |
| 9:128424612:CTGGT:C | donor_loss | 1.0000 |
| 9:128424613:TGGTG:T | donor_loss | 1.0000 |
| 9:128424615:G:GG | donor_gain | 1.0000 |
| 9:128424616:T:A | donor_loss | 1.0000 |
| 9:128428418:CTAG:C | donor_loss | 1.0000 |
| 9:128428420:AGGT:A | donor_loss | 1.0000 |
AlphaMissense
3873 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:128424248:C:A | N179K | 0.998 |
| 9:128424248:C:G | N179K | 0.998 |
| 9:128428337:G:T | G268W | 0.997 |
| 9:128428338:G:A | G268E | 0.997 |
| 9:128424249:T:C | F180L | 0.996 |
| 9:128424251:C:A | F180L | 0.996 |
| 9:128424251:C:G | F180L | 0.996 |
| 9:128424252:T:A | W181R | 0.996 |
| 9:128424252:T:C | W181R | 0.996 |
| 9:128424244:C:T | S178F | 0.995 |
| 9:128424434:T:C | Y196H | 0.995 |
| 9:128422917:T:A | W83R | 0.994 |
| 9:128422917:T:C | W83R | 0.994 |
| 9:128424254:G:C | W181C | 0.994 |
| 9:128424254:G:T | W181C | 0.994 |
| 9:128424486:T:A | V213D | 0.994 |
| 9:128424477:T:A | V210D | 0.993 |
| 9:128428324:T:A | N263K | 0.993 |
| 9:128428324:T:G | N263K | 0.993 |
| 9:128428338:G:T | G268V | 0.993 |
| 9:128424214:C:A | A168D | 0.992 |
| 9:128424250:T:C | F180S | 0.992 |
| 9:128428337:G:A | G268R | 0.992 |
| 9:128428337:G:C | G268R | 0.992 |
| 9:128423215:G:C | K126N | 0.991 |
| 9:128423215:G:T | K126N | 0.991 |
| 9:128424243:T:C | S178P | 0.991 |
| 9:128424244:C:A | S178Y | 0.991 |
| 9:128424435:A:G | Y196C | 0.991 |
| 9:128424448:G:C | K200N | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000025818 (9:128432507 C>G), RS1000116297 (9:128436015 C>T), RS1000304861 (9:128436933 C>G), RS1000335034 (9:128420706 G>A,C), RS1000433108 (9:128430932 C>T), RS1000454858 (9:128434808 C>G,T), RS1001046655 (9:128420334 G>T), RS1001048968 (9:128427511 C>T), RS1001112394 (9:128427203 C>T), RS1001226267 (9:128432859 G>A), RS1001279481 (9:128421867 T>G), RS1001445915 (9:128430817 A>C,G), RS1001497286 (9:128419818 G>A), RS1001699832 (9:128417687 G>T), RS1001730853 (9:128417365 G>T)
Disease associations
OMIM: gene MIM:616626 | disease phenotypes:
GenCC curated gene-disease
Mondo (1): infantile epilepsy syndrome (MONDO:0020071)
Orphanet (1): OBSOLETE: Infantile epilepsy syndrome (Orphanet:98258)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003252_2 | Systemic lupus erythematosus | 2.000000e-06 |
| GCST005951_65 | Body mass index | 5.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression, increases expression | 3 |
| aristolochic acid I | decreases expression | 1 |
| bisphenol F | increases expression | 1 |
| 2,4,6-tribromophenol | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| deoxynivalenol | decreases expression | 1 |
| decabromobiphenyl ether | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| abrine | decreases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | increases expression | 1 |
| pentabrominated diphenyl ether 100 | increases expression | 1 |
| hexabrominated diphenyl ether 153 | increases expression | 1 |
| bisphenol S | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | increases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| Nickel | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): infantile epilepsy syndrome